Exact Mass: 219.194667
Exact Mass Matches: 219.194667
Found 128 metabolites which its exact mass value is equals to given mass value 219.194667,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Miglustat
Miglustat is a drug used to treat Gaucher disease. It inhibits the enzyme glucosylceramide synthase, an essential enzyme for the synthesis of most glycosphingolipids. It is only used for patients who cannot be treated with enzyme replacement therapy with imiglucerase. It is marketed under the trade name Zavesca. Miglustat is now the first and only approved therapy for patients with Niemann-Pick disease type C (NP-C). It has recently been approved for treatment of progressive neurological symptoms in adult and pediatric patients in the European Union, Brazil, and South Korea. A - Alimentary tract and metabolism > A16 - Other alimentary tract and metabolism products > A16A - Other alimentary tract and metabolism products > A16AX - Various alimentary tract and metabolism products D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D007004 - Hypoglycemic Agents > D065089 - Glycoside Hydrolase Inhibitors C471 - Enzyme Inhibitor > C2846 - Glucosidase Inhibitor D004791 - Enzyme Inhibitors
3-(1-Propyl-3-piperidinyl)phenol
D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists
(-)-7-Demethyl-desoxynupharidin|(9aS)-4t-furan-3-yl-1c-methyl-(9ar)-octahydro-quinolizine
2-Hydroxymethyl-5-(1-hydroxypentyl)-3,4-pyrrolidinediol
6-Ethoxy-2,3,4-trimethyl-1,2,3,4-tetrahydroquinoline
CONFIDENCE standard compound; INTERNAL_ID 1319; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7195; ORIGINAL_PRECURSOR_SCAN_NO 7194 CONFIDENCE standard compound; INTERNAL_ID 1319; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7200; ORIGINAL_PRECURSOR_SCAN_NO 7199 CONFIDENCE standard compound; INTERNAL_ID 1319; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7217; ORIGINAL_PRECURSOR_SCAN_NO 7215 CONFIDENCE standard compound; INTERNAL_ID 1319; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7214; ORIGINAL_PRECURSOR_SCAN_NO 7212 CONFIDENCE standard compound; INTERNAL_ID 1319; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7230; ORIGINAL_PRECURSOR_SCAN_NO 7229 CONFIDENCE standard compound; INTERNAL_ID 1319; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7237; ORIGINAL_PRECURSOR_SCAN_NO 7236
(5R,8R)-8-ethyl-5-(pent-4-yn-1-yl)octahydroindolizine
(5S,8R)-8-ethyl-5-(penta-2,4-dien-1-yl)octahydroindolizine
(5R,8R)-5-((E)-but-2-en-1-yl)-8-propyl-1,2,3,5,8,8a-hexahydroindolizine
miglustat
A - Alimentary tract and metabolism > A16 - Other alimentary tract and metabolism products > A16A - Other alimentary tract and metabolism products > A16AX - Various alimentary tract and metabolism products D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D007004 - Hypoglycemic Agents > D065089 - Glycoside Hydrolase Inhibitors C471 - Enzyme Inhibitor > C2846 - Glucosidase Inhibitor D004791 - Enzyme Inhibitors
(S)-TERT-BUTYL (1,5-DIHYDROXYPENTAN-2-YL)CARBAMATE
1-METHYL-4-(PIPERIDIN-4-YL)PIPERAZINE HYDROCHLORIDE
(S)-5-METHOXY-N-PROPYL-1,2,3,4-TETRAHYDRONAPHTHALEN-2-AMINE
N-methyl-1-[1-(pyridin-3-ylmethyl)piperidin-4-yl]methanamine
N-{3-[Dimethoxy(methyl)silyl]propyl}-1-butanamine
C10H25NO2Si (219.16544700000003)
Quinoline, 4-ethoxy-1,2,3,4-tetrahydro-2,6,7-trimethyl- (9CI)
3-Butyl-1,2-dimethyl-1H-imidazol-3-ium dicyanoazanide
1H-Azepine-3-Methanol, hexahydro-1-(phenylMethyl)-
N-[(4-ethylphenyl)methyl]-1-(oxolan-2-yl)methanamine
[4-[(4-METHYLPIPERAZIN-1-YL)METHYL]PHENYL]METHYLAMINE
1-(4-CHLORO-2-NITROPHENYL)-3-METHYLPIPERAZINE HYDROCHLORIDE
Lucerastat
C471 - Enzyme Inhibitor Lucerastat, the galactose form of Miglustat, is an orally-available inhibitor of glucosylceramide synthase (GCS). Lucerastat has the potential for Fabry disease study[1][2].
Quinpirole
D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist
Cinobufotenine
C13H19N2O+ (219.14973039999998)
D009676 - Noxae > D011042 - Poisons > D014688 - Venoms
4-hydroxy-N,N,N-trimethyltryptamine
C13H19N2O+ (219.14973039999998)
2,6,9-Trimethyl-13-oxatetracyclo[6.3.1.1(6,9).0(1,5)]tridecane carbocation
3-(1-Propyl-3-piperidinyl)phenol
D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists
5-Propyl-1,4,4a,6,7,8,8a,9-octahydropyrazolo[3,4-g]quinoline
5-HTQ
C13H19N2O+ (219.14973039999998)
D009676 - Noxae > D011042 - Poisons > D014688 - Venoms
(R)-Preclamol
(R)-Preclamol is a dopamine (DA) agonist with autoreceptor as well as postsynaptic receptor stimulatory properties. (R)-Preclamol inhibits the locomotor activity of mice and rats in low doses[1].
(2s,2's)-sedamine
{"Ingredient_id": "HBIN006613","Ingredient_name": "(2s,2's)-sedamine","Alias": "NA","Ingredient_formula": "C14H21NO","Ingredient_Smile": "CN1CCCCC1CC(C2=CC=CC=C2)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "19632","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6-c-butyl-dmdp
{"Ingredient_id": "HBIN012289","Ingredient_name": "6-c-butyl-dmdp","Alias": "NA","Ingredient_formula": "C10H21NO4","Ingredient_Smile": "CCCCC(C1C(C(C(N1)CO)O)O)O","Ingredient_weight": "219.28 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2792","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10443411","DrugBank_id": "NA"}